gastroesophageal%20reflux%20disease%20in%20children
GASTROESOPHAGEAL REFLUX DISEASE IN CHILDREN

Gastroesophageal reflux is categorized as a disease [gastroesophageal reflux disease (GERD)] when reflux is associated with warning signs &/or complications, & requires further evaluation.

It is more common in formula-fed infants than in purely breastfed infants.

There is increased incidence in infants at 4 months of age.

Definition

  • Gastroesophageal reflux (GER) is the normal physiologic passage of gastric contents into the esophagus
  • Gastroesophageal reflux is categorized as a disease [gastroesophageal reflux disease (GERD)] when reflux is associated with warning signs &/or complications, & requires further evaluation

Epidemiology

  • Frequency of physiologic regurgitation decreases as a child reaches the 1st year of life, & eventually resolves by 12-18 months of age
  • More common in formula-fed infants than in purely breastfed infants
  • Increased incidence in infants 4 months of age

Etiology

  • Produced by various mechanisms such as frequent occurrence of transient relaxation of the lower esophageal sphincter (LES), pressure abnormalities in the lower esophageal sphincter
    • Other factors in the pathology of gastroesophageal reflux disease include poor esophageal clearance, delayed gastric emptying time, hiatal hernia 
  • Genetic predisposition have been associated with the diagnosis of gastroesophageal reflux disease

Signs and Symptoms

  • Infants <12 months of age:
    • Refusal to eat
    • Recurrent vomiting
    • Poor weight gain
    • Irritability
    • Sleep disturbance
    • Respiratory symptoms (coughing, wheezing, choking)
    • Upper airway symptoms (prolonged/chronic cough, hoarseness) 
  • Children ≥1 year of age & adolescents:
    • Abdominal pain/heartburn
    • Recurrent vomiting
    • Dysphagia
    • Asthma
    • Recurrent pneumonia

Warning Signs

  • Gastrointestinal tract bleeding (hematemesis, hematochezia)
  • Abdominal tenderness/distension, palpable abdominal mass
  • Bilious vomiting
  • Projectile vomiting
  • Fever
  • Lethargy, irritability
  • Hepatosplenomegaly
  • Seizures
  • Bulging fontanelle
  • Positive for genetic/metabolic syndrome

Risk Factors

  • Neurological impairment
  • Obesity
  • History of esophageal atresia repair
  • Hiatal hernia
  • Achalasia
  • Chronic respiratory disease (idiopathic interstitial fibrosis, cystic fibrosis, bronchopulmonary dysplasia)
  • Lung transplantation
  • Preterm infants
  • Certain genetic disorders
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
19 Jun 2019
Acquired immunodeficiency syndrome (AIDS) remains as one of the world’s leading causes of mortality in global public health. Dr Charles Hicks shared his insights into the increasing role of dolutegravir (DTG; Tivicay, GSK) – an integrase strand transfer inhibitor (INSTI) – in HIV therapy during the 4th National AIDS Conference 2018 at Swiss Garden International Hotel and Residences, Kuala Lumpur.
2 days ago
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, 3 days ago
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 15 hours ago
Patients with rheumatoid arthritis (RA) who maintained their disease remission had a significantly reduced risk of clinical and subclinical atherosclerosis, according to the 3-year follow-up data of the GIRRCS* study presented at EULAR 2019.